Native Meta creative and exact outbound link observed October 22, 2026. Redirects were followed to the captured public destination. Advertiser claims are source material; activity does not establish performance. No personal, health or payment details were entered.

A treatment offer develops through customer stories, product education, the care process and a clear purchase entry. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
The speech bubbles around the vial are a playful way to deliver pricing claims, and the No kidding bubble adds a bit of personality to a category that's usually stiff. The calm green palette and the single product give it a fresh, clean feel that suits the headline. Placing the Trustpilot rating with 4K reviews and the LegitScript seal in one row at the bottom puts proof right next to the link prompt.
There's no price anywhere in the image and no reason behind the “Act now!” line, which makes it urgency without a cause. The headline, Start fresh, could also sit on almost any product, so the ad never says who it's for or what they're starting fresh from. Add the $166 price to the frame, replace the urgency with a true reason to start (the price lock for new members, which the landing page states) and name the situation in the headline.
The clean, calm scene supports the fresh-start idea visually.
It offers a new beginning, though without naming what the viewer is moving on from.
The playful bubbles make pricing claims feel conversational.
It pairs proof with the action, though the urgency has no stated reason.
The image shows no price; the ad's headline offers Tirzepatide at $166/month (if approved), with fine print noting a three-month minimum that renews for $499 every 11 weeks.
The ad sends people to tirzepatidewoo.brellohealth.com, a dedicated Tirzepatide offer page rather than the homepage or a quiz, and it's one of 18 Brello ads in the library that point there. The page supplies the price the ad left out, with the hero showing $166 a month and the $499 three-month plan, and its price lock notice for new members (no extra fees, no hikes if your dosage changes, no price increases at renewal) is exactly the kind of reason to act this ad could have used. The fresh-start language doesn't reappear in the hero. Brello's Sermorelin page uses a Fresh Start heading over its reviews, so the idea already exists in the brand's own copy and could carry onto this page too.
Brello's dedicated Tirzepatide offer page opens on a $166 a month special with the three-month plan box, then moves through reviews, treatment education, a four-step care path, inclusions and FAQs. It's where 18 Brello ads in the library land, all static image ads, built on emotional moments, native-style text posts and offer or inclusion lists.
A price lock banner, the vial with a $166 badge, and a plan box with the $499 three-month plan, Trustpilot rating, transfer note and intake explanation, answering what it costs and what happens when you pay.
Trusted by 80,000+ members with a Trustpilot rating and review cards about community, customer service and members' own results, answering whether people like you have done this.
A deeper look inside Tirzepatide, with a short explanation, a list of what studies examine, footnoted sources and a results-may-vary note, answering what the medication is.
A straightforward path to care in four photo steps (select your plan, provider review, ships to your door, ongoing support), answering how the process works.
What makes Brello different, with six inclusions beside a photo and a Take the First Step button, answering what you get beyond the medication.
Six questions on approval, refunds, timelines and replacements, then the study references, disclaimers and plan terms, answering the last practical doubts.
Read the full breakdown of this page
One of 22 Brello Health ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.